{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Ledgewood",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91140",
      "recalling_firm": "ImprimisRx NJ",
      "address_1": "1705 Us Highway 46 Ste 4",
      "address_2": "N/A",
      "postal_code": "07852-9720",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0060-2023",
      "product_description": "Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.",
      "product_quantity": "960 bottles",
      "reason_for_recall": "Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.",
      "recall_initiation_date": "20221109",
      "center_classification_date": "20221114",
      "termination_date": "20230823",
      "report_date": "20221123",
      "code_info": "Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023"
    }
  ]
}